New Weight-Loss shot enters first human safety trial
Disease control
Not yet recruiting
This early-stage study tests an experimental drug called CMS-D008 in 110 healthy and overweight or obese adults. The main goal is to check safety and how the body processes the drug, not weight loss. Participants will receive either the drug or a placebo as injections, and resear…
Phase: PHASE1 • Sponsor: Shenzhen Kangzhe Biotechnology Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC